MASTER CONSULTING AGREEMENTConsulting Agreement • November 8th, 2022 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 8th, 2022 Company Industry JurisdictionThis Consulting Agreement (the “MCA”) is made and entered into by and between CytomX Therapeutics, Inc., a Delaware corporation, with an address at 151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080, (“Company”) and Carlos Campoy, located at [***] (“Consultant”), effective as of October 1, 2022 (“Effective Date”).
MASTER CONSULTING AGREEMENTConsulting Agreement • November 8th, 2022 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 8th, 2022 Company Industry JurisdictionThis Consulting Agreement (the “MCA”) is made and entered into by and between CytomX Therapeutics, Inc., a Delaware corporation, with an address at 151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080, (“Company”) and Dr. Amy Peterson, located at [***] (“Consultant”), effective as of September 13, 2022 (“Effective Date”).